Literature DB >> 3124010

Sodium-valproate-induced interstitial nephritis.

C Y Lin1, H Chiang.   

Abstract

A 5-year-old Chinese girl had had absence seizures and received sodium valproate (VPA) treatment which provided good control. Six months later, she developed interstitial nephritis with proteinuria and microhematuria. Renal biopsy revealed interstitial nephritis with granular deposition of immunoglobulin G (IgG) and C3 in the renal tubular basement membrane (TBM). Ultrastructurally, dilated smooth endoreticular cisternae with mitochondrial degeneration in the tubular cells and scattered electron-dense deposits within the TBM were also noted. Serum circulating immune complexes were detectable, ACH50 and properdin factor B increased. Mononuclear cells (MNC) from the patient after in vitro incubation with VPA (100 micrograms/ml) induced interleukin-2 (IL-2) production and lymphoproliferative response. However, there was no response in controls. The serum VPA level ranged from 84 to 92 micrograms/ml. After VPA was stopped, the microhematuria and proteinuria disappeared. These observations indicate that VPA-induced interstitial nephritis represents a sequence of interrelationships among multiple immunologic factors.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3124010     DOI: 10.1159/000184867

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  9 in total

1.  Anticonvulsant-induced rickets and nephrocalcinosis.

Authors:  Keith K Lau; Koyelle Papneja
Journal:  BMJ Case Rep       Date:  2012-02-25

2.  Risk factors for sodium valproate-induced renal tubular dysfunction.

Authors:  Satoko Koga; Takahisa Kimata; Sohsaku Yamanouchi; Shoji Tsuji; Ken Yoshimura; Atsushi Araki; Kazunari Kaneko
Journal:  Clin Exp Nephrol       Date:  2017-08-23       Impact factor: 2.801

3.  Secondary renal Fanconi syndrome caused by valproate therapy.

Authors:  Toru Watanabe; Hideto Yoshikawa; Sawako Yamazaki; Yuki Abe; Tokinari Abe
Journal:  Pediatr Nephrol       Date:  2005-03-23       Impact factor: 3.714

4.  Urinary N-acetyl-beta-D-glucosaminidase in epileptic children treated with antiepileptic drugs.

Authors:  L Csáthy; A V Oláh; B Clemens; I György; J Varga
Journal:  Arch Dis Child       Date:  2000-11       Impact factor: 3.791

5.  A case of acute renal failure in a patient recently treated with clozapine and a review of previously reported cases.

Authors:  J Daniel Kanofsky; Mary E Woesner; Alexander Z Harris; James P Kelleher; Karen Gittens; Elina Jerschow
Journal:  Prim Care Companion CNS Disord       Date:  2011

6.  Reversible acute renal failure associated with clomipramine-induced interstitial nephritis.

Authors:  Akira Onishi; Hisashi Yamamoto; Tetsu Akimoto; Osamu Saito; Makoto Inoue; Yasuhiro Ando; Shigeaki Muto; Eiji Kusano
Journal:  Clin Exp Nephrol       Date:  2007-09-28       Impact factor: 2.801

7.  Renal tubular dysfunction following treatment with anti-epileptic drugs.

Authors:  R Korinthenberg; L Wehrle; L B Zimmerhackl
Journal:  Eur J Pediatr       Date:  1994-11       Impact factor: 3.183

Review 8.  The effects of sodium valproate on the renal function of children with epilepsy.

Authors:  Mark Jonathan Knights; Eric Finlay
Journal:  Pediatr Nephrol       Date:  2013-05-30       Impact factor: 3.714

9.  Protective effects of fennel oil extract against sodium valproate-induced hepatorenal damage in albino rats.

Authors:  Wael M Al-Amoudi
Journal:  Saudi J Biol Sci       Date:  2016-11-05       Impact factor: 4.219

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.